1. New insights into genetic mechanism of HIV drug resistance;Larder,1999
2. Serious adverse events contributed to nevirapine regimes for post-exposure prophylaxis after HIV exposures – worldwide, 1997 to 2000;MMWR Morb Mortal Wkly Rep,2001
3. Antiretroviral teatments to reduce mother-to-child transmission of HIV;Periperl
4. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial;Guay;Lancet,1999
5. The one year safety and efficacy data of the HIVNET 012 trial;Owor,2000